1. Home
  2. QUBT vs VCEL Comparison

QUBT vs VCEL Comparison

Compare QUBT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$8.13

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.43

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
VCEL
Founded
2001
1989
Country
United States
United States
Employees
77
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
QUBT
VCEL
Price
$8.13
$33.43
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$17.50
$57.75
AVG Volume (30 Days)
12.9M
533.3K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
60.00
EPS
N/A
0.32
Revenue
$682,000.00
$276,259,000.00
Revenue This Year
$3,210.56
$19.40
Revenue Next Year
$51.26
$18.24
P/E Ratio
N/A
$112.05
Revenue Growth
82.84
16.45
52 Week Low
$6.18
$28.95
52 Week High
$25.84
$45.97

Technical Indicators

Market Signals
Indicator
QUBT
VCEL
Relative Strength Index (RSI) 48.15 46.65
Support Level $7.70 $31.24
Resistance Level $9.15 $34.77
Average True Range (ATR) 0.68 1.52
MACD -0.01 0.05
Stochastic Oscillator 40.71 10.17

Price Performance

Historical Comparison
QUBT
VCEL

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: